EphrinB2 knockdown in cervical spinal cord preserves diaphragm innervation in a mutant SOD1 mouse model of ALS

Mark W Urban,Brittany A Charsar,Nicolette M Heinsinger,Shashirekha S Markandaiah,Lindsay Sprimont,Wei Zhou,Eric V Brown,Nathan T Henderson,Samantha J Thomas,Biswarup Ghosh,Rachel E Cain,Davide Trotti,Piera Pasinelli,Megan C Wright,Matthew B Dalva,Angelo C Lepore

DOI: https://doi.org/10.7554/elife.89298

IF: 7.7

2024-01-16

eLife

Abstract:Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by motor neuron loss. Importantly, non-neuronal cell types such as astrocytes also play significant roles in disease pathogenesis. However, mechanisms of astrocyte contribution to ALS remain incompletely understood. Astrocyte involvement suggests that transcellular signaling may play a role in disease. We examined contribution of transmembrane signaling molecule ephrinB2 to ALS pathogenesis, in particular its role in driving motor neuron damage by spinal cord astrocytes. In symptomatic SOD1 G93A mice (a well-established ALS model), ephrinB2 expression was dramatically increased in ventral horn astrocytes. Reducing ephrinB2 in the cervical spinal cord ventral horn via viral-mediated shRNA delivery reduced motor neuron loss and preserved respiratory function by maintaining phrenic motor neuron innervation of diaphragm. EphrinB2 expression was also elevated in human ALS spinal cord. These findings implicate ephrinB2 upregulation as both a transcellular signaling mechanism in mutant SOD1-associated ALS and a promising therapeutic target.

biology